NO972304L - Vitamin D3-analoger - Google Patents

Vitamin D3-analoger

Info

Publication number
NO972304L
NO972304L NO972304A NO972304A NO972304L NO 972304 L NO972304 L NO 972304L NO 972304 A NO972304 A NO 972304A NO 972304 A NO972304 A NO 972304A NO 972304 L NO972304 L NO 972304L
Authority
NO
Norway
Prior art keywords
chj
hydroxy
hydrogen
analogues
vitamin
Prior art date
Application number
NO972304A
Other languages
English (en)
Other versions
NO972304D0 (no
Inventor
Andrew David Batcho
Graeme Findlay Bryce
Bernard Michael Hennessy
Jerome Anthony Iacobelli
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO972304D0 publication Critical patent/NO972304D0/no
Publication of NO972304L publication Critical patent/NO972304L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Forbindelser med formel HO hvor R er hydrogen, fluor eller hydroksy, Rj er hydrogen, lavere alkyl eller halogen, X er =CH2, eller når R er hydroksy, er X (H,H) eller =CH2, og A cr -C=C- \ / c=c c=c / \ eller -CHj-CHj-, er nyttige ved behandling av hyperproli- ferative hudforstyrrelser, neoplaBtiske sykdommer, sebaceuse kjertelsykdommer og tilstander forbundet med hud skadet av sollys .
NO972304A 1996-05-23 1997-05-21 Vitamin D3-analoger NO972304L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1818696P 1996-05-23 1996-05-23
US1815396P 1996-05-23 1996-05-23
US3990097P 1997-03-19 1997-03-19

Publications (2)

Publication Number Publication Date
NO972304D0 NO972304D0 (no) 1997-05-21
NO972304L true NO972304L (no) 1997-11-24

Family

ID=27360973

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972304A NO972304L (no) 1996-05-23 1997-05-21 Vitamin D3-analoger

Country Status (29)

Country Link
EP (2) EP1464640A3 (no)
JP (1) JP2859247B2 (no)
KR (1) KR100783856B1 (no)
CN (1) CN1176072C (no)
AR (1) AR007241A1 (no)
AT (1) ATE277008T1 (no)
AU (1) AU723929B2 (no)
BR (1) BR9703384A (no)
CA (1) CA2205275C (no)
CO (1) CO4950531A1 (no)
CZ (1) CZ157897A3 (no)
DE (1) DE69730774T2 (no)
DK (1) DK0808833T3 (no)
ES (1) ES2227635T3 (no)
HR (1) HRP970273A2 (no)
HU (1) HUP9700926A3 (no)
IL (1) IL120843A0 (no)
MA (1) MA24251A1 (no)
NO (1) NO972304L (no)
NZ (1) NZ314839A (no)
PE (1) PE70198A1 (no)
PL (1) PL320132A1 (no)
PT (1) PT808833E (no)
SG (1) SG70009A1 (no)
TR (1) TR199700415A2 (no)
TW (1) TW445252B (no)
UY (1) UY24561A1 (no)
YU (1) YU20197A (no)
ZA (1) ZA974336B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939408A (en) 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
AU737376B2 (en) * 1997-02-25 2001-08-16 Regents Of The University Of Michigan, The Methods and compositions for preventing and treating chronological aging in human skin
WO1998051678A1 (en) * 1997-05-16 1998-11-19 Women & Infants Hospital CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1α (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF
DE69834109T2 (de) * 1997-05-16 2007-04-19 Woman & Infants Hospital 3-epi-vitamin d2 verbindungen und ihre anwendungen
EP0957098A1 (en) * 1998-05-14 1999-11-17 F. Hoffmann-La Roche Ag Intermediates for the synthesis of 3-epi vitamin D3 metabolites and analogs
US6603030B1 (en) 1999-04-22 2003-08-05 Hoffman-La Roche Inc. Process for producing phosphineoxide vitamin D precursors
ES2388425T5 (es) * 1999-04-23 2020-02-12 Leo Pharma As Composición farmacéutica no acuosa para uso dérmico para tratar la psoriasis que comprende una vitamina D, un corticoesteroide y un componente disolvente
US6255501B1 (en) * 1999-04-26 2001-07-03 Hoffman-La Roche Inc. Process for preparing antiosteoporotic agents
US20020045606A1 (en) * 1999-12-02 2002-04-18 Reddy Satyanarayana G. Esters of vitamin D3 and uses thereof
SG110107A1 (en) 2003-09-24 2005-04-28 Bioxell Spa Compound and use in treatment
GB2407499B (en) * 2003-11-03 2008-02-27 Bioxell Spa Vitamin D3 analogue for use in the treatment of BPH
BRPI0404050A (pt) * 2003-09-24 2005-06-14 Bioxell Spa Uso de um composto ou de um seu sal ou éster farmaceuticamente aceitável, formulação farmacêutica, formulação acondicionada, composto, e, método para prevenir e/ou tratar hiperplasia benigna da próstata em pacientes em necessidade de tal prevenção ou tratamento
BRPI0508333A (pt) 2004-03-01 2007-07-17 Bioxell Spa uso de um composto de vitamina d, método de prevenir e/ou tratar cistite intersticial, formulação farmacêutica, composto de vitamina d, e, kit
EP1812011A1 (en) 2004-11-12 2007-08-01 Bioxell S.p.a. Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
WO2006113990A2 (en) * 2005-04-25 2006-11-02 Cytochroma Inc. LOW-CALCEMIC 16,23-DIENE 25-OXIME ANALOGS OF 1α ,25-DIHYDROXY VITAMIN D3
EP1924268A2 (en) * 2005-08-18 2008-05-28 Bioxell S.p.a. Synthesis of 1alpha-fluoro-25-hydroxy-16-23e-diene-26,27-bishomo-20-epi-cholecalciferol
TW200838544A (en) * 2007-01-25 2008-10-01 Bioxell Spa Synthesis of 1 α-fluoro-25-hydroxy-16-23E-diene-26, 27-bishomo-20-epi-cholecalciferol
JP5480131B2 (ja) 2007-05-30 2014-04-23 シトクロマ インコーポレイテッド ホスフィンオキシドビタミンｄ前駆物質の製造方法
ES2366077B2 (es) * 2010-03-30 2012-06-25 Universidade De Vigo Compuestos quirales, procedimientos de obtención y uso.
HUE025554T2 (en) * 2010-10-25 2016-02-29 Teijin Pharma Ltd Vitamin D3-23-in derivative
KR101812860B1 (ko) * 2012-11-07 2017-12-27 브이아이디 스케일, 인크. Ｈｄｒ 비디오를 디노이징하기 위한 시간적 필터
CN105348164B (zh) * 2015-10-29 2017-03-29 无锡福祈制药有限公司 一种1α‑羟基维生素D2的制备方法
CN106748942B (zh) * 2016-11-28 2018-06-29 无锡福祈制药有限公司 度骨化醇类似物wxfq-65及其合成方法
ES2731558B2 (es) * 2018-05-15 2020-03-18 Univ Santiago Compostela Compuestos de interés farmacéutico
CN109738252B (zh) * 2019-01-23 2021-03-09 深圳天辰医疗科技有限公司 25-羟基-维生素d解离液
CN109696435B (zh) * 2019-01-25 2021-03-09 深圳天辰医疗科技有限公司 维生素d的测定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
ES2091515T3 (es) * 1992-05-20 1996-11-01 Hoffmann La Roche Analogos fluorados de la vitamina d3.
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
JP3228488B2 (ja) * 1993-12-24 2001-11-12 株式会社クラレ ２０−エピステロイド誘導体およびその製造方法

Also Published As

Publication number Publication date
TW445252B (en) 2001-07-11
EP0808833B1 (en) 2004-09-22
PE70198A1 (es) 1998-11-26
MX9703774A (es) 1998-06-30
AU723929B2 (en) 2000-09-07
CA2205275A1 (en) 1997-11-23
TR199700415A3 (tr) 1997-12-21
KR970074765A (ko) 1997-12-10
MA24251A1 (fr) 1998-04-01
HRP970273A2 (en) 1998-04-30
EP1464640A3 (en) 2005-01-12
IL120843A0 (en) 1997-09-30
CN1175573A (zh) 1998-03-11
NO972304D0 (no) 1997-05-21
ES2227635T3 (es) 2005-04-01
ATE277008T1 (de) 2004-10-15
EP0808833A2 (en) 1997-11-26
SG70009A1 (en) 2000-01-25
DK0808833T3 (da) 2005-01-31
CO4950531A1 (es) 2000-09-01
NZ314839A (en) 2000-01-28
EP1464640A2 (en) 2004-10-06
BR9703384A (pt) 1998-09-15
HUP9700926A3 (en) 1999-05-28
PL320132A1 (en) 1997-11-24
CA2205275C (en) 2007-04-03
YU20197A (sh) 1999-09-27
JP2859247B2 (ja) 1999-02-17
UY24561A1 (es) 2000-12-29
HU9700926D0 (en) 1997-07-28
AU2357797A (en) 1997-11-27
TR199700415A2 (xx) 1997-12-21
EP0808833A3 (en) 1998-11-25
DE69730774T2 (de) 2005-09-29
HUP9700926A2 (hu) 1998-01-28
KR100783856B1 (ko) 2008-05-09
AR007241A1 (es) 1999-10-27
DE69730774D1 (de) 2004-10-28
ZA974336B (en) 1997-11-24
PT808833E (pt) 2004-11-30
CN1176072C (zh) 2004-11-17
CZ157897A3 (en) 1997-12-17
JPH1045713A (ja) 1998-02-17

Similar Documents

Publication Publication Date Title
CA2205275A1 (en) Vitamin d3 analogs
ATE45942T1 (de) Diarylacetylene, ihre herstellung und verwendung.
DE69304279D1 (de) Fluorierte Analoge Vitamins D3
NO971934L (no) Flourinerte vitamin D3 -analoger
NO913728D0 (no) Fremgangsmaate for fremstilling av benzimidazolderivater.
GR3002618T3 (en) Solutions of oxazaphosphorins with enhanced stability and process for their preparation
DE68903437D1 (de) Piperidin-derivate.
DE59001281D1 (de) Oxidierte diphenylheteroalkane, ihre herstellung und verwendung.
NO934197L (no) Vitamin D-3-analoger
ATE1625T1 (de) Isoxazolylcarbonsaeureanilide, ihre herstellung, diese enthaltende fungizide mittel und verfahren zur bekaempfung von pilzen.
AU5516590A (en) Dehydrocholecalciferol derivatives
AU640647B2 (en) 3-butenamide derivatives
ATE10361T1 (de) Derivate von 3-phenoxy-2-propanolen, ihre herstellung und ihre therapeutische verwendung.
ATE10370T1 (de) Benzothiazinderivate, verfahren zu ihrer herstellung und ihre verwendung.
EP0796843A3 (en) 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives
ATE17485T1 (de) 3,7a-diazacyclohepta(j,k)fluorenderivate, ihre herstellung und ihre therapeutische verwendung.
ATE18039T1 (de) 2,3,5,6-tetrasubstituierte p-benzochinone, ihre herstellung und verwendung.
DE3785232D1 (de) Analoge der methylthioribose, ihre herstellung sowie medizinische und biozide verwendung.
JPS55164833A (en) Sensitizer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application